These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 23247028)

  • 21. Squalene isolated from Schizochytrium mangrovei is a peroxisome proliferator-activated receptor-α agonist that regulates lipid metabolism in HepG2 cells.
    Hoang TM; Nguyen CH; Le TT; Hoang TH; Ngo TH; Hoang TL; Dang DH
    Biotechnol Lett; 2016 Jul; 38(7):1065-71. PubMed ID: 26956235
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Fucosterol is a selective liver X receptor modulator that regulates the expression of key genes in cholesterol homeostasis in macrophages, hepatocytes, and intestinal cells.
    Hoang MH; Jia Y; Jun HJ; Lee JH; Lee BY; Lee SJ
    J Agric Food Chem; 2012 Nov; 60(46):11567-75. PubMed ID: 23116181
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Differential effects of peroxisome proliferator-activated receptor activators on the mRNA levels of genes involved in lipid metabolism in primary human monocyte-derived macrophages.
    Cabrero A; Cubero M; Llaverías G; Jové M; Planavila A; Alegret M; Sánchez R; Laguna JC; Carrera MV
    Metabolism; 2003 May; 52(5):652-7. PubMed ID: 12759900
    [TBL] [Abstract][Full Text] [Related]  

  • 24. C333H, a novel PPARalpha/gamma dual agonist, has beneficial effects on insulin resistance and lipid metabolism.
    Xu C; Wang LL; Liu HY; Zhou XB; Cao YL; Li S
    Acta Pharmacol Sin; 2006 Feb; 27(2):223-8. PubMed ID: 16412273
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Importance of PPAR alpha for the effects of growth hormone on hepatic lipid and lipoprotein metabolism.
    Ljungberg A; Lindén D; Améen C; Bergström G; Oscarsson J
    Growth Horm IGF Res; 2007 Apr; 17(2):154-64. PubMed ID: 17307376
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ligand- and structure-based drug design strategies and PPARδ/α selectivity.
    Maltarollo VG; Honório KM
    Chem Biol Drug Des; 2012 Oct; 80(4):533-44. PubMed ID: 22672760
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ethyl 2,4,6-trihydroxybenzoate is an agonistic ligand for liver X receptor that induces cholesterol efflux from macrophages without affecting lipid accumulation in HepG2 cells.
    Hoang MH; Jia Y; Jun HJ; Lee JH; Lee DH; Hwang BY; Kim WJ; Lee HJ; Lee SJ
    Bioorg Med Chem Lett; 2012 Jun; 22(12):4094-9. PubMed ID: 22579484
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Role of PPARalpha in mediating the effects of phthalates and metabolites in the liver.
    Lapinskas PJ; Brown S; Leesnitzer LM; Blanchard S; Swanson C; Cattley RC; Corton JC
    Toxicology; 2005 Feb; 207(1):149-63. PubMed ID: 15590130
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Farnesol, an isoprenoid, improves metabolic abnormalities in mice via both PPARα-dependent and -independent pathways.
    Goto T; Kim YI; Funakoshi K; Teraminami A; Uemura T; Hirai S; Lee JY; Makishima M; Nakata R; Inoue H; Senju H; Matsunaga M; Horio F; Takahashi N; Kawada T
    Am J Physiol Endocrinol Metab; 2011 Nov; 301(5):E1022-32. PubMed ID: 21862726
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Improvement of dyslipidemia, insulin sensitivity, and energy balance by a peroxisome proliferator-activated receptor alpha agonist.
    Chen X; Matthews J; Zhou L; Pelton P; Liang Y; Xu J; Yang M; Cryan E; Rybczynski P; Demarest K
    Metabolism; 2008 Nov; 57(11):1516-25. PubMed ID: 18940388
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Peroxisome proliferator-activated receptor alpha is involved in the regulation of lipid metabolism by ginseng.
    Yoon M; Lee H; Jeong S; Kim JJ; Nicol CJ; Nam KW; Kim M; Cho BG; Oh GT
    Br J Pharmacol; 2003 Apr; 138(7):1295-302. PubMed ID: 12711630
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Integrated virtual screening for the identification of novel and selective peroxisome proliferator-activated receptor (PPAR) scaffolds.
    Nevin DK; Peters MB; Carta G; Fayne D; Lloyd DG
    J Med Chem; 2012 Jun; 55(11):4978-89. PubMed ID: 22582973
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [PPARs: physiological functions and pharmacological roles of agonists in human diseases. Note II].
    Filip-Ciubotaru F; Manciuc C; Grigore C; Foia L
    Rev Med Chir Soc Med Nat Iasi; 2012; 116(1):240-7. PubMed ID: 23077903
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of Paralichthys olivaceus peroxisome proliferator-activated receptor-α gene as a master regulator of flounder lipid metabolism.
    Cho HK; Kong HJ; Kim HY; Cheong J
    Gen Comp Endocrinol; 2012 Jan; 175(1):39-47. PubMed ID: 22051321
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Identification, organ expression and ligand-dependent expression levels of peroxisome proliferator activated receptors in grass carp (Ctenopharyngodon idella).
    He S; Liang XF; Qu CM; Huang W; Shen D; Zhang WB; Mai KS
    Comp Biochem Physiol C Toxicol Pharmacol; 2012 Mar; 155(2):381-8. PubMed ID: 22079418
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Structure-activity relationship studies of non-carboxylic acid peroxisome proliferator-activated receptor α/δ (PPARα/δ) dual agonists.
    Okazaki S; Shioi R; Noguchi-Yachide T; Ishikawa M; Makishima M; Hashimoto Y; Yamaguchi T
    Bioorg Med Chem; 2016 Nov; 24(21):5455-5461. PubMed ID: 27622746
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Gypenoside XLIX isolated from Gynostemma pentaphyllum inhibits nuclear factor-kappaB activation via a PPAR-alpha-dependent pathway.
    Huang TH; Li Y; Razmovski-Naumovski V; Tran VH; Li GQ; Duke CC; Roufogalis BD
    J Biomed Sci; 2006 Jul; 13(4):535-48. PubMed ID: 16525884
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Identification of dual PPARα/γ agonists and their effects on lipid metabolism.
    Gao Q; Hanh J; Váradi L; Cairns R; Sjöström H; Liao VW; Wood P; Balaban S; Ong JA; Lin HY; Lai F; Hoy AJ; Grewal T; Groundwater PW; Hibbs DE
    Bioorg Med Chem; 2015 Dec; 23(24):7676-84. PubMed ID: 26616289
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Activation of Peroxisome Proliferator-Activated Receptors α and δ Synergizes with Inflammatory Signals to Enhance Adoptive Cell Therapy.
    Saibil SD; St Paul M; Laister RC; Garcia-Batres CR; Israni-Winger K; Elford AR; Grimshaw N; Robert-Tissot C; Roy DG; Jones RG; Nguyen LT; Ohashi PS
    Cancer Res; 2019 Feb; 79(3):445-451. PubMed ID: 30573521
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A novel LXR-alpha activator identified from the natural product Gynostemma pentaphyllum.
    Huang TH; Razmovski-Naumovski V; Salam NK; Duke RK; Tran VH; Duke CC; Roufogalis BD
    Biochem Pharmacol; 2005 Nov; 70(9):1298-308. PubMed ID: 16154115
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.